- Trials with a EudraCT protocol (14)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
14 result(s) found for: Chondrocyte.
Displaying page 1 of 1.
| EudraCT Number: 2015-003584-11 | Sponsor Protocol Number: MACT-IBK-2015 | Start Date*: 2015-12-11 | ||||||||||||||||
| Sponsor Name:Medical University Innsbruck | ||||||||||||||||||
| Full Title: Matrix-associated autologous chrondrocyte transplantation for grade four cartilage lesions of the knee joint - clinical and radiological outcome in correlation to the initial cell count of the cho... | ||||||||||||||||||
| Medical condition: Cartilage lesion | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: AT (Completed) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2016-003418-28 | Sponsor Protocol Number: CLNA043X2201 | Start Date*: 2017-04-18 | |||||||||||
| Sponsor Name:Novartis Pharma AG | |||||||||||||
| Full Title: A randomized, placebo-controlled, patient and investigator blinded, single dose, Proof of Concept study investigating the safety, tolerability and preliminary efficacy of intra-articular LNA043 in ... | |||||||||||||
| Medical condition: Acute cartilage injuries | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: AT (Prematurely Ended) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2007-003481-18 | Sponsor Protocol Number: CART.III. | Start Date*: 2008-11-17 |
| Sponsor Name:TBF | ||
| Full Title: PHASE III PROTOCOL COMPARING A MICROFRACTURE TREATMENT TO A CARTIPATCH® CHONDROCYTE GRAFT TREATMENT IN FEMORAL CONDYLE LESIONS | ||
| Medical condition: Femoral condyles single lesion from trauma or osteochondritis dissequans with invalidant signs | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2015-005162-34 | Sponsor Protocol Number: clinical_study_protocol | Start Date*: 2017-05-19 | |||||||||||
| Sponsor Name:University Hospital Basel | |||||||||||||
| Full Title: Randomized, multi-center phase II clinical trial for the regeneration of cartilage lesions in the knee using nasal chondrocyte-based tissue (NTEC) or nasal chondrocyte-based cell (N-CAM)-therapies | |||||||||||||
| Medical condition: Patients must display 1-2 symptomatic, focal cartilage lesion grade IIIIV (according to the grading by the International Cartilage Repair Society (ICRS)) from 2 to 8 cm2 on the femoral condyle and/... | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) HR (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2016-000784-16 | Sponsor Protocol Number: NCPACI | Start Date*: 2016-04-15 |
| Sponsor Name:Akershus University Hospital | ||
| Full Title: Focal cartilage defects in the knee – A randomized controlled trial comparing Autologous Chondrocyte Implantation with arthroscopic debridement | ||
| Medical condition: Symptomatic focal cartilage defects in the knee | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NO (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-002507-32 | Sponsor Protocol Number: IBD8 | Start Date*: 2004-10-11 |
| Sponsor Name:Royal Hospital For Sick Children, Yorkhill Division | ||
| Full Title: Effect of recombinant growth hormone on growth and chondrocyte dynamics in children with Inflammatory bowel disease (IBD) and growth failure. | ||
| Medical condition: Growth retardation secondary to inflammatory bowel disease in children | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2004-004153-25 | Sponsor Protocol Number: JIA6 | Start Date*: 2004-12-10 |
| Sponsor Name:Royal Hospital For Sick Children, Yorkhill Division | ||
| Full Title: Effect of recombinant growth hormone on growth and chondrocyte dynamics in children with juvenile idiopathic arthritis (JIA) and growth failure. | ||
| Medical condition: Growth retardation secondary to juvenile idiopathic arthritis | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: GB (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2010-023830-22 | Sponsor Protocol Number: AAG-G-H-1102 | Start Date*: 2012-05-23 | |||||||||||
| Sponsor Name:TETEC AG | |||||||||||||
| Full Title: NDisc Study: A Prospective Randomized Multicentre Phase I / II Clinical Trial to Evaluate Safety and Efficacy of NOVOCART® Disc plus Autologous Disc Chondrocyte Transplantation (ADCT) in the Treatm... | |||||||||||||
| Medical condition: The subject has a disc herniation with back and /or leg pain (radicular pain) and an identification for sequestrectomy according to the guidelines of DGNC and DGOOC. | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) AT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2014-004120-21 | Sponsor Protocol Number: COX1985 | Start Date*: 2016-01-22 | |||||||||||
| Sponsor Name:FUNDACIÓN PÚBLICA ANDALUZA PROGRESO Y SALUD | |||||||||||||
| Full Title: CLINICAL TRIAL RANDOMIZED, DOUBLE-BLIND CONTROLLED, PHASE III, TO EVALUATE THE USE OF PLATELET RICH PLASMA IN FRONT HYALURONIC ACID IN COXARTHROSIS. | |||||||||||||
| Medical condition: coxarthrosis | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2009-016970-33 | Sponsor Protocol Number: MACI00809 | Start Date*: 2011-03-17 | ||||||||||||||||
| Sponsor Name:Genzyme Europe BV | ||||||||||||||||||
| Full Title: An Extension Protocol for Participants of Genzyme-Sponsored Prospective, Randomized, Open-Label, Parallel-Group, Multicenter Study of Matrix-Induced Autologous Chondrocyte Implantation (MACI® impl... | ||||||||||||||||||
| Medical condition: Symptomatic Articular Cartilage Defects of the Femoral Condyle including the Trochlea. Osteochondritis dissecans lesions that do not require a bone graft. | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | |||||||||||||||||
| Trial protocol: NL (Completed) CZ (Completed) GB (Completed) SE (Completed) PL (Completed) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2006-004817-16 | Sponsor Protocol Number: MACI00206 | Start Date*: 2008-01-23 | ||||||||||||||||
| Sponsor Name:Genzyme Europe B.V. | ||||||||||||||||||
| Full Title: A Prospective, Randomized, Open-Label, Parallel-Group, Multicenter Study to Demonstrate the Superiority of Matrix-induced Autologous Chondrocyte Implantation (MACI® implant) versus Arthroscopic Mi... | ||||||||||||||||||
| Medical condition: Symptomatic Articular Cartilage Defects of the Femoral Condyle including the Trochlea. osteochondritis dissecans lesions that do not require a bone graft. | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | |||||||||||||||||
| Trial protocol: GB (Completed) CZ (Completed) SE (Completed) NL (Completed) PL (Completed) DE (Prematurely Ended) | ||||||||||||||||||
| Trial results: View results | ||||||||||||||||||
| EudraCT Number: 2009-016466-82 | Sponsor Protocol Number: cod16HS13 | Start Date*: 2010-09-01 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Sponsor Name:CO.DON AG | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Full Title: Prospective, randomised, open label, multicentre Phase-III clinical trial to compare the efficacy and safety of the treatment with the autologous chondrocyte transplantation product co.don chondros... | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Medical condition: Cartilage defects of knee joints, osteochondral defects | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trial protocol: DE (Completed) PL (Completed) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trial results: View results | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| EudraCT Number: 2011-005798-22 | Sponsor Protocol Number: AAG-G-H-1202 | Start Date*: 2012-11-05 | ||||||||||||||||||||||||||
| Sponsor Name:TETEC – Tissue Engineering Technologies – AG | ||||||||||||||||||||||||||||
| Full Title: A Clinical Study to Evaluate the Safety and Effectiveness of NOVOCART® 3D plus Compared to Microfracture in the Treatment of Articular Cartilage Defects of the Knee. | ||||||||||||||||||||||||||||
| Medical condition: Repair of localized, full-thickness cartilage defects of the femoral condyle (medial, lateral or trochlea) of 2-6cm². | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
| Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
| Trial protocol: DE (Completed) AT (Completed) GB (GB - no longer in EU/EEA) CZ (Completed) PL (Completed) HU (Completed) LV (Completed) LT (Completed) FR (Completed) | ||||||||||||||||||||||||||||
| Trial results: View results | ||||||||||||||||||||||||||||
| EudraCT Number: 2009-016816-20 | Sponsor Protocol Number: cod16HS14 | Start Date*: 2010-05-24 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Sponsor Name:co.don AG | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Full Title: Prospective, randomised, open label, multicentre Phase II clinical trial to investigate the efficacy and safety of the treatment of large defects (4-10 cm2) with 3 different doses of the autologous... | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Medical condition: Cartilage defects of knee joints, osteochondral defects | |||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trial results: View results | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.